EWF
GILD icon

Epstein & White Financial’s Gilead Sciences GILD Stock Holding History

Epstein & White Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,119
Closed -$456K – 80
2020
Q1 		$456K Sell
6,119
-4,050
-40% -$280K 0.19% 38
2019
Q4 		$657K Buy
+10,169
New +$662K 0.29% 35

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Epstein & White Financial's GILD Position: Q2 2020 in Review

Epstein & White Financial sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 6,119 shares — an estimated $456K sold.

Epstein & White Financial first reported a position in GILD in Q4 2019 and held it in 2 quarters. The position peaked at $657K in Q4 2019. 1,625 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Epstein & White Financial reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
  • Epstein & White Financial sold 6,119 Gilead Sciences shares in Q2 2020, an estimated $456K.
  • Epstein & White Financial first reported a position in Gilead Sciences in Q4 2019 and held it in 2 quarters.
  • Epstein & White Financial's Gilead Sciences position peaked at $657K in Q4 2019.
  • 1,625 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Epstein & White Financial's 13F filing for Q2 2020, filed 22 Jul 2020.